Private equity giant Thoma Bravo has raised its first-ever European-focused fund, securing €1.8 billion ($1.9B) to invest in mid-sized software companies across the continent.
Private equity giant Thoma Bravo has raised its first-ever European-focused fund, securing €1.8 billion ($1.9B) to invest in mid-sized software companies across the continent.
Perplexity AI, the AI-powered search engine startup, has launched a $50 million venture fund to invest in seed and pre-seed startups, particularly in the AI and search technology space.
New York-based Patlytics, an AI-driven patent analytics platform, has raised $14 million in Series A funding to scale its intellectual property (IP) research and litigation tools.
Cherryrock Capital, the venture firm founded by former TaskRabbit CEO Stacy Brown-Philpot, has raised $172 million for its first fund, with backing from JPMorgan, Goldman Sachs, MassMutual, Pivotal Ventures (Melinda French Gates), Reid Hoffman, Mellody Hobson, and Sheryl Sandberg.
Afore Capital, a venture firm specializing in pre-seed investments, has raised $185 million for its fourth fund, expanding its ability to back early-stage founders.
Austin-based defense tech startup Saronic has secured $600 million in Series C funding to develop Port Alpha, an advanced factory for producing autonomous warships.
Augury, an industrial AI startup specializing in machine health monitoring, has secured $75 million in Series F funding, pushing its valuation past $1 billion.
As uncertainty looms over NIH funding, biotech leaders are stepping up with alternative financing solutions. Chris Gibson, co-founder and CEO of Recursion, along with serial biotech entrepreneur David Bearss, has launched the Altitude Lab Pre-seed Venture Fund, aimed at supporting early-stage biotech startups that typically rely on Small Business Innovation
Hightouch, a customer data platform (CDP) and AI-driven marketing automation startup, has secured $80 million in Series C funding, doubling its valuation to $1.2 billion.
